pk 11195 has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 1 studies
PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine
Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zunino, SJ | 1 |
| Storms, DH | 1 |
1 other study available for pk 11195 and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Resveratrol-induced apoptosis is enhanced in acute lymphoblastic leukemia cells by modulation of the mitochondrial permeability transition pore.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cells, Cultured; Cyclosporine; Dose-Response Relations | 2006 |